To view the PDF file, sign up for a MySharenet subscription.

IMBALIE BEAUTY LIMITED - Lapse of sale of shares by major shareholders, update on iBLOOM transaction, update on postponement of GM

Release Date: 15/12/2021 10:43
Code(s): ILE     PDF:  
Wrap Text
Lapse of sale of shares by major shareholders, update on iBLOOM transaction, update on postponement of GM

Imbalie Beauty Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2003/025374/06)
(Share Code: ILE ISIN: ZAE000165239)
("Imbalie Beauty" or "the Company")
____________________________________________________________________________
LAPSE OF SALE OF SHARES BY MAJOR SHAREHOLDERS, UPDATE ON IBLOOM
TRANSACTION, UPDATE ON POSTPONEMENT OF GENERAL MEETING AND
WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT

  1. Sale of shares by major shareholders

     Shareholders are referred to the SENS announcements dated 28 June 2021,
     3 August 2021, 15 September 2021, 28 October 2021 and 3 December 2021 in which it
     was announced that Holistics Remedies (Pty) Ltd, SA Madiba Investments (Pty) Ltd,
     Unihold Group (Pty) Ltd and Esna Colyn ("Major Shareholders”), who are major
     shareholders and/or directors of Imbalie Beauty, entered into a written sale of shares
     agreement ("Sale of Shares Agreement"), dated 24 June 2021, with Shenver Investments
     (Pty) Ltd and Baxfex (Pty) Ltd (collectively the "Purchasers"), to sell some of their shares
     in Imbalie Beauty (“Subject Shares”) to the Purchasers.

     Shareholders are advised that the Sale of Shares Agreement has lapsed as certain of the
     suspensive conditions to which it is subject have not been fulfilled and accordingly the
     Sale of Shares Agreement is not to be implemented.

     The Major Shareholders have however been approached by an investor who has indicated
     his desire to purchase the Subject Shares at the same consideration from the Major
     Shareholders. Shareholders will be advised once the new sale of shares agreement has
     been entered into.

  2. Update on iBLOOM transaction and postponement of general meeting

     Shareholders are also referred to the SENS announcement dated 6 July 2021 in which it
     was announced that Imbalie Beauty entered into a written sale of shares and claims
     agreement ("Disposal Agreement"), dated 24 June 2021, with iBLOOM (Pty) Ltd
     ("iBLOOM"), in terms of which Imbalie Beauty sold to iBLOOM all its shares in and claims
     against the wholly owned subsidiaries of Imbalie Beauty. Shareholders are also referred
     to the circular sent to shareholders on 3 November 2021.
     The Sale of Shares Agreement and the Disposal Agreement were entered into as one
     indivisible transaction and, if the Sale of Shares Agreement terminates, the Disposal
     Agreement automatically lapses.
     In light of the potential new disposal of the Subject Shares as contemplated in paragraph
     1. above, Imbalie Beauty and iBLOOM have agreed to enter into a written revival
     agreement (“Revival Agreement”), pursuant to which Revival Agreement the Disposal
     Agreement will be revived.
   Imbalie Beauty has therefore determined that the postponed general meeting will be held
   as detailed below.
 Salient dates and details:
  ISSUER NAME                                               Imbalie Beauty Limited
  TYPE OF INSTRUMENT                                              Ordinary Shares
  ISIN NUMBER                                                      ZAE000165239
  JSE CODE                                                                     ILE
  MEETING TYPE                                                    General Meeting
  MEETING VENUE                                                       Electronic meeting
  RECORD DATE – to determine which
  shareholders are entitled to receive the
  Notice of meeting                                         Friday, 3 December 2021
  PUBLICATION/POSTING DATE                             Wednesday, 15 December 2021
  LAST DAY TO TRADE – Last day to trade to
  determine eligible shareholders that may
  attend, speak and vote at the Meeting                        Tuesday, 4 January 2022
  RECORD DATE- Record date to determine
  eligible shareholders that may attend, speak
  and vote at the Meeting                                        Friday, 7 January 2022
  MEETING DEADLINE DATE (For
  administrative purposes, forms of proxy for
  the meeting to be lodged by 10:00 on                         Friday, 14 January 2022
  MEETING DATE at 10:00 on                                    Monday, 17 January 2022
  PUBLICATION OF RESULTS                                      Monday, 17 January 2022
  WEB SITE LINK                                               www.imbaliebeauty.co.za

   A notice will be mailed to shareholders on 15 December 2021 informing them of the re-
   scheduled general meeting.

3. Withdrawal of cautionary announcement

   Shareholders are advised that they no longer need to exercise caution when dealing
   in the Company’s securities.

4. Responsibility statement

   The Independent Board of Imbalie Beauty and the directors of iBLOOM:

   -   have considered all statements of fact and opinion in this announcement;
   -   accept, individually and collectively, full responsibility for the accuracy of the
       information given;
   -   certify that, to the best of their knowledge and belief, there are no omissions of material
       facts or considerations which would make any statement of fact or opinion contained
       in this document false or misleading;
     -   have made all reasonable enquiries in this regard; and
      -   confirm that this announcement contains all information required by the Regulations.

15 December 2021
Woodmead

Designated Advisor
Exchange Sponsors

Date: 15-12-2021 10:43:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story